Skip to main content
Elsevier

Journals in Pharmacology

Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.

  • Pulmonary Pharmacology & Therapeutics

    • ISSN: 1094-5539
    Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews.Research Areas Include:• All major diseases of the lung • Physiology • Pathology • Drug delivery • Metabolism • Pulmonary ToxicologyBefore submitting, please note the "Rules of 5" defining immediate rejection criteria of PPT:1. Out of scope: The paper should report on the use of pharmacological or toxicological studies (positive or negative) that are directly related to Pulmonary Pharmacology & Therapeutics.Immedia... rejection criteria are: a) Testing of extracts or plant parts that are not characterized b) Case Reports or n=1 studies2. Too preliminary: A paper must be based on a thorough and extensive study, using proper controlsImmediate rejection criteria are: a) In vitro studies with a single dose, or very high concentration b) Single dose studies with very few animals, no dose-response studies c) No proper controls. d) Repetition or confirmation of an earlier work3. Unethical: The study must have been carried under appropriate ethical approval for the study (either animal or human).4. Inappropriate experiments or lacking essential detailImmediate rejection criteria are: a) Wrong species or lacking details on the exact number of animals/subjects used b) No details of structure if a new drug is used for the first time5. Lack of novelty: The study must represent a novel approach to the field.Immediate rejection criteria are: a) Repetition of well known data b) No advance of knowledge in the fieldNote that only manuscripts written in good English will be considered by the Editors (British usage is preferred).
    Subscriptions

  • Environmental Toxicology and Pharmacology

    • ISSN: 1382-6689
    Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man.Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxicokinetics (including toxicokinetic modelling), molecular, biochemical and physiological mechanisms explaining differences in sensitivity between species and individuals, the characterisation of pathophysiological models and mechanisms involved in the development of effects and the identification of biological markers that can be used to study exposure and effects in man and animals.In addition to full length papers, short communications, full-length reviews and mini-reviews, Environmental Toxicology and Pharmacology will publish in depth assessments of special problem areas. The latter publications may exceed the length of a full length paper three to fourfold. A basic requirement is that the assessments are made under the auspices of international groups of leading experts in the fields concerned. The information examined may either consist of data that were already published, or of new data that were obtained within the framework of collaborative research programmes. Provision is also made for the acceptance of minireviews on (classes of) compounds, toxicities or mechanisms, debating recent advances in rapidly developing fields that fall within the scope of the journal.
    Subscriptions

  • Molecular Aspects of Medicine

    • ISSN: 0098-2997
    Molecular Aspects of Medicine is a review journal for Physicians and Biomedical Scientists and an official journal of the International Union of Biochemistry and Molecular Biology. Molecular Aspects of Medicine aims to encourage the bridging of the gap between clinicians of all relevant specialities and biomedical scientists. The journal anticipates that most of the authors contributing to the series will be practising clinical scientists who will develop their own personal perspective as an extended review on the molecular aspects of a field of medicine in which they are working, addressing themselves both to the doctor who is ill-at-ease with basic science, and to the basic scientist with little awareness of the problems of clinical practice.It publishes articles on a spectrum of topics in medicine to illustrate not only the molecular insights that derive from the application of basic science, but also the variety of challenging problems that medicine is able to offer the basic scientist.Submission... on from biochemistry and molecular and cell biology to physiology, pharmacology and pathology are particularly welcomed.
    Subscriptions

  • Journal of Ethnopharmacology

    • ISSN: 0378-8741
    The Journal of Ethnopharmacology is the Official Journal of the International Society for Ethnopharmacology. The journal is dedicated to the exchange of information and understandings about people's use of plants, fungi, animals, microorganisms and minerals and their biological and pharmacological effects based on the principles established through international conventions.The Journal of Ethnopharmacology publishes original articles concerned with the observation and experimental investigation of the biological activities of plant and animal substances used in the traditional medicine of past and present cultures, which document indigenous medical knowledge, study indigenous medicines in order to contribute in the long-run to improved health care in the regions of study, and which report on pharmacologically unique principles from existing indigenous remedies.The journal will particularly welcome interdisciplinary papers with an ethnopharmacological... an ethnobotanical or an ethnochemical approach to the study of indigenous drugs. It is imperative that experimental studies are aligned and related to the traditional use(s).Furthermore:R... of anthropological and ethnobotanical field studies fall within the journal's scope.Studies involving pharmacological and toxicological mechanisms of action are especially welcome.Clinical studies on efficacy will be considered if contributing to the understanding of specific ethnopharmacological problems.The journal welcomes review articles in the above-mentioned fields especially those highlighting the multi-disciplinary nature of ethnopharmacology.
    Subscriptions

  • Pharmacology Biochemistry and Behavior

    • ISSN: 0091-3057
    Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely biochemical or toxicology studies will not be published.Papers describing the behavioral effects of novel drugs in models of psychiatric, neurological and cognitive disorders, and central pain must include a positive control unless the paper is on a disease where such a drug is not available yet.Papers focusing on physiological processes (e.g., peripheral pain mechanisms, body temperature regulation, seizure activity) are not accepted as we would like to retain the focus of Pharmacology Biochemistry & Behavior on behavior and its interaction with the biochemistry and neurochemistry of the central nervous system.Papers describing the effects of plant materials are generally not considered, unless the active ingredients are studied, the extraction method is well described, the doses tested are known, and clear and definite experimental evidence on the mechanism of action of the active ingredients is provided.
    Subscriptions

  • Schizophrenia Research

    • ISSN: 0920-9964
    An International Multidisciplinary Journal of the Schizophrenia International Research SocietyAs an official journal of the Schizophrenia International Research Society (SIRS) Schizophrenia Research is THE journal of choice for international researchers and clinicians to share their work with the global schizophrenia research community. More than 6000 institutes have online or print (or both) access to this journal - the largest specialist journal in the field, with the largest readership!Schizophr... Research's time to first decision is as fast as 6 weeks and its publishing speed is as fast as 4 weeks until online publication (corrected proof/Article in Press) after acceptance and 14 weeks from acceptance until publication in a printed issue.The journal publishes novel papers that really contribute to understanding the biology and treatment of schizophrenic disorders; Schizophrenia Research brings together biological, clinical and psychological research in order to stimulate the synthesis of findings from all disciplines involved in improving patient outcomes in schizophrenia.Manusc... with a focus on cognition in schizophrenia can be submitted to the journal's open access companion title, Schizophrenia Research: Cognition.
    Subscriptions

  • European Journal of Cancer

    • ISSN: 0959-8049
    Official Journal of EORTC and EUSOMAThe European Journal of Cancer (EJC) integrates preclinical, digital, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care.  Within its digital oncology scope, the journal welcomes high-quality studies on artificial intelligence, machine learning, computational imaging and pathology, digital biomarkers, real-world data, electronic health record-based research, digital therapeutics, clinical decision support, large language models and other digital health applications relevant to cancer prevention, diagnosis, treatment, survivorship and patient care. The journal prioritises digital and AI studies that are clinically grounded, methodologically robust, transparently reported, appropriately validated, and that consider generalisability, reproducibility, patient safety, privacy, equity and potential sources of bias.  The journal publishes original research, reviews, previews, editorial comments and correspondence.The EJC is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Breast Cancer Specialists (EUSOMA).
    Subscriptions

  • Free Radical Biology & Medicine

    • ISSN: 0891-5849
    The journal Free Radical Biology and Medicine is the premier forum for publishing ground-breaking research in the redox biology of both health and disease. We focus on signal transduction and redox signaling; oxidative stress; reductive stress; redox stress; nitrosative stress; aging and age-related diseases; redox biology in skeletal and cardiac muscle, exercise science, and sports medicine; metabolic regulation and metabolic diseases; mitochondrial function and signaling; homeostatic mechanisms and adaptive responses; redox chemistry and mechanisms; materials and nanomaterials; non-thermal plasmas; microorganisms, fungi, plants, insects, animals, and humans; and antioxidant enzymes, pathways, and networks.The journal welcomes both full-length and short Research Communications, Hypothesis Papers, Reviews, Mini Reviews, Graphical Reviews, and Critical Methods Papers. Free Radical Biology and Medicine is the official journal of the Society for Redox Biology and Medicine and the Society for Free Radical Research-Europe, and affiliate journal of the International Society for Free Radical Research (SFRRI)
    Subscriptions

  • Toxicology and Applied Pharmacology

    • ISSN: 0041-008X
    Toxicology and Applied Pharmacology publishes original scientific research of relevance to animals or humans pertaining to the action of chemicals, drugs, or chemically-defined natural products.Regular articles address mechanistic approaches to physiological, pharmacologic, biochemical, cellular, or molecular understanding of toxicologic/patholog... lesions and to methods used to describe these responses. Safety Science articles address outstanding state-of-the-art preclinical and human translational characterization of drug and chemical safety employing cutting-edge science. Highly significant Regulatory Safety Science articles will also be considered in this category. Papers concerned with alternatives to the use of experimental animals are encouraged.Short articles report on high impact studies of broad interest to readers of TAAP that would benefit from rapid publication. These articles should contain no more than a combined total of four figures and tables. Authors should include in their cover letter the justification for consideration of their manuscript as a short article.TAAP also issues a standing call for outstanding Invited Review Articles. Potential authors should contact the Editor-In-Chief and complete an Invited Review Proposal Form before preparing or submitting their Review Article.
    Subscriptions

  • Fitoterapia

    • ISSN: 0367-326X
    The Journal for the Study of Medicinal PlantsA Q1-ranked journal in the category of 'Agricultural and Biological Sciences' (Scopus).Fitoterapia is a Journal dedicated to medicinal plants and fungi and to the bioactive natural products produced by these organisms. It publishes original contributions in six major areas:Chemical characterization of active ingredients of medicinal plants and fungi, including their endophytes Innovative analytical approaches for dereplication and standardization of bioactive extracts and metabolites from plant resources Identification of bioactivity in plant and fungal extracts and in their constituents Identification of biological targets and mechanism of activity of plant and fungal extracts Production and genomic characterization of medicinal plants biomass Critical reviews of the composition, history, clinical and legal status of medicinal plants, and accounts on topical issues. Publication requirementsWestern Blots. Manuscripts reporting Western Blots must include original uncropped traces in triplicate as Supplementary Material. Images should be of good resolution.NMR data. Manuscripts reporting the structure elucidation of new compounds must include copies of MS and 1D and 2D NMR spectra as Supplementary Material. Fitoterapia strongly encourages Authors to deposit raw NMR data files (FID and 2D serial files) for new compounds in a publicly accessible data depository. Reviews. For review article submissions, Authors are required to provide evidence of their expertise and research experience in the specific field. Contributions reporting the following are NOT considered for publication: Activity data on crude extracts that have not been characterized by qualitative (and preferably quantitative) analysis of their individual constituents (LC/MS, or isolation followed by NMR). Data on the extract composition simply taken from literature or from previous studies are not acceptable. Characterization of only a few constituents is generally considered too partial. Studies on the bioactivity of pure compounds purchased or obtained by Authors without any study or relationship with the producing organism. Unexceptional and predictable bioactivity (e.g. antioxidant and mild antimicrobial properties of phenolics or of essential oils). Uncritical ethnopharmacological investigations, where a list of plants and their use are simply recorded. Genomic, transcriptomic and pharmacological studies without convincing wet lab experiments, or with little correlation to bioactive natural compounds.Studies based exclusively or mainly on computational/theore... investigations without adequate experimental support.In addition, the following immediate rejection criteria apply: RULE 1: The manuscript does not fall into any of the areas of interest of the Journal (e.g. investigation on extracts obtained from animal sources) RULE 2: The manuscript is too preliminary, reporting e.g. activity data without comparison to a reference, or without a positive control. RULE 3: The botanical source is not clearly identified (with scientific Latin names), authenticated, and documented (voucher). RULE 4: Lack of the required supporting material (see publication requirements). RULE 5: Bioactivity is not relevant to in vivo situations. RULE 6: Reviews on topics already covered in the recent literature. RULE 7: Bibliometric or patentometric reviews.
    Subscriptions

Related subjects